Tauriga Sciences Inc. (TAUG) 0.0036 $TAUG
Tauriga Sciences Inc. to Showcase TopiCanna Cream and Other Natural Wellness Products at the 2015 Northern California Cannabis Cup
PR Newswire - Fri Jun 12, 9:49AM CDT
Tauriga Sciences, Inc. (OTCQB: TAUG) or ("Tauriga" or "the Company"
, a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology, today announced that the Company will have a booth at the Northern California Cannabis Cup to be held in San Francisco, California on June 20-21, 2015 (http://www.cannabiscup.com/norcal/). Tauriga's booth at the event will feature the Company's cannabidiol (CBD) products, TopiCanna cream and CannaCaviar soft gels, as well as Tauriga's natural wellness supplements. Tauriga will also be marketing Breathe eCig Corp.'s second generation e-cigarettes at its booth, under a revenue sharing arrangement.
Tauriga Sciences, Inc. Extinguishes All Further Obligations to Typenex Co-Investment LLC with One-Time Cash Payment of $230,000 USD
PR Newswire - Tue Jun 02, 12:08PM CDT
Tauriga Sciences, Inc. (OTCQB: TAUG) ("Tauriga" or the "Company" , a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology, today announced that it has officially extinguished all further obligations to Typenex Co-Investment, LLC ("Typenex" in exchange for a one-time cash payment of $230,000 USD. On January 16, 2015, the Company and Typenex entered into a Settlement Agreement (the "Settlement Agreement" as fully disclosed in a Current Report on Form 8-K filed with Securities and Exchange Commission on January 23, 2015. The Settlement Agreement was entered into between the Company and Typenex to settle litigation between the parties previously disclosed in the Company's Quarterly Report on Form 10-Q filed on November 19, 2014 regarding 70,080,714 shares of the Company's common stock, par value $0.001, Typenex believed it was due under a purported warrant issued in connection and arising from a convertible promissory note issued by the Company to Typenex on June 24, 2013.
Tauriga Sciences, Inc. to Present at Cannabis Investor Webcast
PR Newswire - Tue Jun 02, 7:30AM CDT
Tauriga Sciences, Inc. (OTCQB:TAUG) ("Tauriga" or the "Company" , a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology will be presenting on the Cannabis Investor Webcast on Tuesday, June 4, 2015 at 12:00 pm EDT/9:00 am PDT.
Tauriga Sciences, Inc. Subsidiary Pilus Energy to Participate in 2015 World Environmental & Water Resources Congress
PR Newswire - Fri May 15, 7:30AM CDT
Tauriga Sciences, Inc. (OTCQB: TAUG) ("Tauriga" or the "Company" , a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology, is pleased to announce that its subsidiary Pilus Energy will be participating in the 2015 World Environmental & Water Resources Congress in Austin, TX May 17-21 at the JW Marriot (110 E. Second St. Austin, TX 78701). Pilus will be presenting at the Sunday poster session from 4:30 pm to midnight. The theme for this year is Floods, Droughts, and Ecosystems: Managing Our Resources Despite Growing Demands and Diminishing Funds.
Tauriga Sciences, Inc. and Cannabis Health Form "Foundational Partnership"
PR Newswire - Wed May 13, 7:15AM CDT
Tauriga Sciences, Inc. (OTCQB: TAUG) ("Tauriga" or the "Company" , a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology, announced today that it has formed a "Foundational Partnership" with Cannabis Health, an information based media company that focuses on the health and science of cannabis. Under this partnership agreement, Tauriga and its principals will provide Cannabis Health with medical and scientific content for Cannabis Health's print and electronic publication and dissemination. Cannabis Health will help increase exposure to Tauriga and its natural wellness products. Both companies will help each other market their shared vision of utilizing cannabis as a natural medicine.
SEC Compliance Featuring Products From Tauriga Sciences, Inc. at B. Riley & Co. Conference
PR Newswire - Mon May 11, 7:00AM CDT
Tauriga Sciences, Inc. (OTCQB: TAUG) ("Tauriga" or the "Company" , a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology, announced today that its products will be featured at the SEC Compliance sponsor booth at this week's 16th Annual B. Riley & Co. Investor Conference on May 12th-14th at The Loews Hollywood Hotel in Los Angeles, California. B. Riley & Co.'s investment conference highlights over 250 publicly-traded companies and dozens of privately-held firms showcasing their stories to an expected audience of institutional investors, corporate clients, and high-net worth individuals.
Breathe eCig Corp. Announces Initial Purchase Order From Knoxville Based Retail & Distribution Partner
PR Newswire - Wed Apr 29, 9:13AM CDT
Breathe eCig Corp. (OTCQB: BVAP) ("Breathe" or "the Company" , electronic cigarette industry innovator and pioneer, has announced that it has received a purchase order for all of its remaining first generation product from Knoxville, Tennessee based distributor Ampa Group ("Ampa" . Ampa, inclusive of its affiliate companies, owns and operates over 30 retail locations, a hospitality portfolio and has a distribution alliance that reaches over 300 unique retailers in the East Tennessee region spanning from Johnson City to Chattanooga. Ampa has also provided the Company with a much larger purchase commitment for the Company's second generation products, including the CBD e-cigarette being co-developed with Tauriga (OTCQB:TAUG). The Company has been working diligently with its Hong Kong based manufacturer, The KMG Group ("KMG" , to ensure delivery of its proprietary second generation device by May 20, 2015. Once the Company is notified by KMG of the exact delivery date of its second generation product, it will notify shareholders via a press release.
Tauriga Sciences Inc. Reports Estimated Quarterly Revenue Growth Exceeding 60% and Provides Shareholder Update
PR Newswire - Thu Apr 23, 12:18PM CDT
Tauriga Sciences, Inc. (OTCQB:TAUG) ("Tauriga" or the "Company" , a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology, has today pre-announced positive quarterly revenues for the first calendar quarter of 2015, which ended on March 31, 2015 (the Company's fourth fiscal quarter of 2015). The Company is pleased to disclose that estimated quarterly revenue growth, as compared to the previous quarter ending December 31, 2014, exceeded 60% and the estimated total quarterly sales are approximately $50,000 USD. These figures are unaudited, and the exact revenue number along with the full financial results of the Company for its fiscal year ended March 31, 2015 will be disclosed in the Company's upcoming Annual Report on Form 10-K.
Reviews Of 15 Marijuana Stocks Before The Marijuana Investor Summit - Part IX
Anthony Cataldo - at Seeking Alpha - Tue Apr 21, 12:43AM CDT
Tauriga Sciences, Inc. to Present at Cannabis Investor Webcast on April 9, 2015
PR Newswire - Tue Apr 07, 7:30AM CDT
Tauriga Sciences, Inc. (OTCQB:TAUG) ("Tauriga" or the "Company" , a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology will be presenting on the Cannabis Investor Webcast on Thursday, April 9, 2015 at 10:00 AM EDT.
Global E-Cigarette Market Trends Points to Significant Growth in Coming Years - Company Enters JV Partnership to Bring E-Cig Products to Native American Gaming Industry Casinos
PR Newswire - Tue Mar 17, 7:55AM CDT
Growth prospects of the E-cigarette market in the U.S. is forecasted to continue to grow in the next few years as many now consider vapor products a replacement to mimic traditional cigarettes. Companies in focus today are Breathe eCig Corp. (OTC: BVAP), Electronic Cigarettes International Group (OTC: ECIG), Vapor Corp. (NASDAQ: VPCO), mCig(R) Inc. (OTC: MCIG), Philip Morris International (NYSE: PM) and The Altria Group (NYSE: MO).
PM: 82.16 (+0.92), MO: 51.31 (+0.36), VPCO: 1.37 (-0.02)
Pot Stock Crash Redux: $23.3B Loss?
Matthew Finston - at Seeking Alpha - Sun Mar 08, 12:42AM CST
48 Marijuana Stocks - A Post-Mortem: Part II
Anthony Cataldo - at Seeking Alpha - Wed Mar 04, 7:36AM CST
INSY: 37.53 (+0.49), FULL: 3.56 (+0.05), CARA: 13.28 (+0.52)
Marijuana Stocks: Seeking Liquidity
Matthew Finston - at Seeking Alpha - Mon Mar 02, 7:24AM CST
Tauriga Sciences, Inc. To Showcase TopiCanna Cream And Other Natural Wellness Products At The 2015 Southern California Cannabis Cup
PR Newswire - Wed Jan 28, 6:45AM CST
Tauriga Sciences, Inc. (OTCQB: TAUG) or ("Tauriga" or "the Company" , a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology, today announced that the Company has entered its branded TopiCanna product into the Southern California Cannabis Cup to be held in San Bernardino, California on February 7-8, 2015 (http://www.cannabiscup.com/southern-california). TopiCanna will compete for an award in the Southern California Cannabis Cup, in the new Medically Infused NonEdible category. This category is reserved for products like lotions, balms, patches and suppositories. Any cannabis infused product that is not eaten or smoked can be entered in this category.
Tauriga Sciences Inc. Appoints Hingge Hsu, M.D., M.B.A. to its Board of Directors
PR Newswire - Tue Jan 20, 7:00AM CST
Tauriga Sciences, Inc. (OTCQB: TAUG) or ("Tauriga" or "the Company" , a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology, announced the appointment of Hingge Hsu, M.D., M.B.A. to its Board of Directors. Dr. Hingge Hsu was recently a Partner at Fidelity Biosciences and was on the core healthcare investment team for Fidelity Growth Partners Asia. He was previously a Managing Director at Lehman Brothers in their Private Equity Group, responsible for their principal investment activities in the private and public sectors of the healthcare industry. Dr. Hsu has structured and led numerous transactions in the life science sector, and he has been instrumental in building and growing his portfolio companies. In addition, Dr. Hsu has held operating positions at Chiron Corporation and Gensia, Inc. in the areas of business development and strategic planning. Dr. Hsu strengthens the Tauriga Board of Directors with his venture capital and investment banking experience, technical and industry knowledge, and an extensive network in both the U.S. and Asia. Moreover, he has personally invested in Tauriga Sciences based on his confidence in their strategic plan.
Tauriga Sciences Inc. Announces the Launch of Its taurigastore.com eCommerce Website
PR Newswire - Thu Jan 08, 9:15AM CST
Tauriga Sciences, Inc. (OTCQB: TAUG) ("Tauriga" or the "Company" , a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology, today launched its http://www.taurigastore.com eCommerce website. This launch allows consumers to shop online with the Company for its non-cannabis containing line of natural wellness dietary supplements. These natural supplements include IndiCalm, natural calming formula without inducing cognitive impairment; ClearNaze, a natural decongestant without stimulant or drowsiness effects; Satietiva, an amino acid-based appetite suppressant (preorder until February 2); and MendCan, a highly pure, potent and palatable Omega 3 supplement.
Tauriga Sciences Confirms that Canadian Trading Halt (Cease Trade) has been Lifted by Autorite des Marches Financiers (Quebec Based regulatory Authority)
PR Newswire - Thu Jan 08, 9:00AM CST
Tauriga Sciences , Inc ("Tauriga" (OTCQB: TAUG) announces that the Autorite des Marches Financiers ("AMF" or "Authority" , the market regulatory authority in the province of Quebec, Canada has lifted its cease trade order relating to Tauriga's securities effective June 23, 2014. Tauriga's common shares were placed on a "cease trade" or "trading halt" in Canada by the Authority for failure to file its financial statements and management's discussion and analysis for the interim fiscal periods ended June 30, 2013, September 30, 2013 and December 31, 2013 and its annual financial statements, management's discussion and analysis and annual information form for the fiscal year ended March 31, 2013 in Canada (collectively, the "Financial Documents" . Although the Financial Documents were filed by Tauriga with the Securities and Exchange Commission as required, the Financial Documents were not filed on SEDAR. The Financial Documents were filed by Tauriga on SEDAR on July 18, 2014 and are available at www.sedar.com.
Tauriga Sciences Inc. Receives Additional $150,000 USD Private Placement Tranche from Tokyo Based Dragoon Capital, Inc.
PR Newswire - Wed Dec 24, 6:30AM CST
Tauriga Sciences, Inc. (OTCQB: TAUG) ("Tauriga" or "the Company" , a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology, today announced that Tokyo, Japan based Dragoon Capital, Inc. ("Dragoon" has invested an additional $150,000 USD of private placement capital into Tauriga. This additional $150,000 USD tranche was invested at a price of $0.0125 per share (Restricted) and there were no warrants offered in conjunction with this financing. To this date, Dragoon has now invested a total of $500,000 USD of private placement capital into Tauriga. The Company plans to use this additional capital to increase production of its TopiCanna brand of topical medicinal cannabis cream and establish a marketing campaign. The Company continues to work diligently toward the completion of the definitive distribution agreement with Japanese distributor iFLOW, Inc. ("iFLOW" . In anticipation of such agreement, the Company has been developing a TopiCanna product specific for the Japanese marketplace that incorporates CBD (Cannabidiol) from the stem of the plant (to comply with the laws and regulations of Japan).
Tauriga Sciences Inc. CBD (Cannabidiol) Infused TopiCanna Products Have Been Officially Launched
ACCESSWIRE - Tue Dec 16, 11:01AM CST
Los Angeles, CA / ACCESSWIRE / December 16, 2014 / Tauriga Sciences, Inc. (OTCQB: TAUG) ("Tauriga" or the "Company" , a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology, today launched its first proprietary topical medicinal cannabis cream branded as TopiCanna. TopiCanna contains cannabidiol (CBD) oil from non-GMO industrial hemp that is grown without pesticides, herbicides, or chemical fertilizers. The oil has been lab tested for quality and is natural, safe and legal in the United States and in Japan, where Tauriga has a recently announced MOU with Tokyo-based iFLOW Ltd. There are no psychoactive effects associated with the CBD oil. Tauriga previously announced on November 25, 2014 that the Company planned to launch its TopiCanna product line within the next 60 days. TopiCanna's launch occurred well within the projected timeline. Initially the TopiCanna Products be sold directly by Tauriga Sciences, Inc. (interested parties may email inquiries to info@taurigasciences.com). The Company plans to expand TopiCanna's sales and marketing efforts to include online sales and distribution agreements, both domestically and internationally.
Tauriga Sciences Inc. to Showcase TopiCanna Cream and Other Natural Wellness Products at the 2015 Northern California Cannabis Cup
PR Newswire - Fri Jun 12, 9:49AM CDT
Tauriga Sciences, Inc. (OTCQB: TAUG) or ("Tauriga" or "the Company"
, a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology, today announced that the Company will have a booth at the Northern California Cannabis Cup to be held in San Francisco, California on June 20-21, 2015 (http://www.cannabiscup.com/norcal/). Tauriga's booth at the event will feature the Company's cannabidiol (CBD) products, TopiCanna cream and CannaCaviar soft gels, as well as Tauriga's natural wellness supplements. Tauriga will also be marketing Breathe eCig Corp.'s second generation e-cigarettes at its booth, under a revenue sharing arrangement. Tauriga Sciences, Inc. Extinguishes All Further Obligations to Typenex Co-Investment LLC with One-Time Cash Payment of $230,000 USD
PR Newswire - Tue Jun 02, 12:08PM CDT
Tauriga Sciences, Inc. (OTCQB: TAUG) ("Tauriga" or the "Company"
, a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology, today announced that it has officially extinguished all further obligations to Typenex Co-Investment, LLC ("Typenex" in exchange for a one-time cash payment of $230,000 USD. On January 16, 2015, the Company and Typenex entered into a Settlement Agreement (the "Settlement Agreement" as fully disclosed in a Current Report on Form 8-K filed with Securities and Exchange Commission on January 23, 2015. The Settlement Agreement was entered into between the Company and Typenex to settle litigation between the parties previously disclosed in the Company's Quarterly Report on Form 10-Q filed on November 19, 2014 regarding 70,080,714 shares of the Company's common stock, par value $0.001, Typenex believed it was due under a purported warrant issued in connection and arising from a convertible promissory note issued by the Company to Typenex on June 24, 2013. Tauriga Sciences, Inc. to Present at Cannabis Investor Webcast
PR Newswire - Tue Jun 02, 7:30AM CDT
Tauriga Sciences, Inc. (OTCQB:TAUG) ("Tauriga" or the "Company"
, a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology will be presenting on the Cannabis Investor Webcast on Tuesday, June 4, 2015 at 12:00 pm EDT/9:00 am PDT. Tauriga Sciences, Inc. Subsidiary Pilus Energy to Participate in 2015 World Environmental & Water Resources Congress
PR Newswire - Fri May 15, 7:30AM CDT
Tauriga Sciences, Inc. (OTCQB: TAUG) ("Tauriga" or the "Company"
, a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology, is pleased to announce that its subsidiary Pilus Energy will be participating in the 2015 World Environmental & Water Resources Congress in Austin, TX May 17-21 at the JW Marriot (110 E. Second St. Austin, TX 78701). Pilus will be presenting at the Sunday poster session from 4:30 pm to midnight. The theme for this year is Floods, Droughts, and Ecosystems: Managing Our Resources Despite Growing Demands and Diminishing Funds. Tauriga Sciences, Inc. and Cannabis Health Form "Foundational Partnership"
PR Newswire - Wed May 13, 7:15AM CDT
Tauriga Sciences, Inc. (OTCQB: TAUG) ("Tauriga" or the "Company"
, a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology, announced today that it has formed a "Foundational Partnership" with Cannabis Health, an information based media company that focuses on the health and science of cannabis. Under this partnership agreement, Tauriga and its principals will provide Cannabis Health with medical and scientific content for Cannabis Health's print and electronic publication and dissemination. Cannabis Health will help increase exposure to Tauriga and its natural wellness products. Both companies will help each other market their shared vision of utilizing cannabis as a natural medicine. SEC Compliance Featuring Products From Tauriga Sciences, Inc. at B. Riley & Co. Conference
PR Newswire - Mon May 11, 7:00AM CDT
Tauriga Sciences, Inc. (OTCQB: TAUG) ("Tauriga" or the "Company"
, a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology, announced today that its products will be featured at the SEC Compliance sponsor booth at this week's 16th Annual B. Riley & Co. Investor Conference on May 12th-14th at The Loews Hollywood Hotel in Los Angeles, California. B. Riley & Co.'s investment conference highlights over 250 publicly-traded companies and dozens of privately-held firms showcasing their stories to an expected audience of institutional investors, corporate clients, and high-net worth individuals. Breathe eCig Corp. Announces Initial Purchase Order From Knoxville Based Retail & Distribution Partner
PR Newswire - Wed Apr 29, 9:13AM CDT
Breathe eCig Corp. (OTCQB: BVAP) ("Breathe" or "the Company"
, electronic cigarette industry innovator and pioneer, has announced that it has received a purchase order for all of its remaining first generation product from Knoxville, Tennessee based distributor Ampa Group ("Ampa" . Ampa, inclusive of its affiliate companies, owns and operates over 30 retail locations, a hospitality portfolio and has a distribution alliance that reaches over 300 unique retailers in the East Tennessee region spanning from Johnson City to Chattanooga. Ampa has also provided the Company with a much larger purchase commitment for the Company's second generation products, including the CBD e-cigarette being co-developed with Tauriga (OTCQB:TAUG). The Company has been working diligently with its Hong Kong based manufacturer, The KMG Group ("KMG" , to ensure delivery of its proprietary second generation device by May 20, 2015. Once the Company is notified by KMG of the exact delivery date of its second generation product, it will notify shareholders via a press release. Tauriga Sciences Inc. Reports Estimated Quarterly Revenue Growth Exceeding 60% and Provides Shareholder Update
PR Newswire - Thu Apr 23, 12:18PM CDT
Tauriga Sciences, Inc. (OTCQB:TAUG) ("Tauriga" or the "Company"
, a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology, has today pre-announced positive quarterly revenues for the first calendar quarter of 2015, which ended on March 31, 2015 (the Company's fourth fiscal quarter of 2015). The Company is pleased to disclose that estimated quarterly revenue growth, as compared to the previous quarter ending December 31, 2014, exceeded 60% and the estimated total quarterly sales are approximately $50,000 USD. These figures are unaudited, and the exact revenue number along with the full financial results of the Company for its fiscal year ended March 31, 2015 will be disclosed in the Company's upcoming Annual Report on Form 10-K. Reviews Of 15 Marijuana Stocks Before The Marijuana Investor Summit - Part IX
Anthony Cataldo - at Seeking Alpha - Tue Apr 21, 12:43AM CDT
Tauriga Sciences, Inc. to Present at Cannabis Investor Webcast on April 9, 2015
PR Newswire - Tue Apr 07, 7:30AM CDT
Tauriga Sciences, Inc. (OTCQB:TAUG) ("Tauriga" or the "Company"
, a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology will be presenting on the Cannabis Investor Webcast on Thursday, April 9, 2015 at 10:00 AM EDT. Global E-Cigarette Market Trends Points to Significant Growth in Coming Years - Company Enters JV Partnership to Bring E-Cig Products to Native American Gaming Industry Casinos
PR Newswire - Tue Mar 17, 7:55AM CDT
Growth prospects of the E-cigarette market in the U.S. is forecasted to continue to grow in the next few years as many now consider vapor products a replacement to mimic traditional cigarettes. Companies in focus today are Breathe eCig Corp. (OTC: BVAP), Electronic Cigarettes International Group (OTC: ECIG), Vapor Corp. (NASDAQ: VPCO), mCig(R) Inc. (OTC: MCIG), Philip Morris International (NYSE: PM) and The Altria Group (NYSE: MO).
PM: 82.16 (+0.92), MO: 51.31 (+0.36), VPCO: 1.37 (-0.02)
Pot Stock Crash Redux: $23.3B Loss?
Matthew Finston - at Seeking Alpha - Sun Mar 08, 12:42AM CST
48 Marijuana Stocks - A Post-Mortem: Part II
Anthony Cataldo - at Seeking Alpha - Wed Mar 04, 7:36AM CST
INSY: 37.53 (+0.49), FULL: 3.56 (+0.05), CARA: 13.28 (+0.52)
Marijuana Stocks: Seeking Liquidity
Matthew Finston - at Seeking Alpha - Mon Mar 02, 7:24AM CST
Tauriga Sciences, Inc. To Showcase TopiCanna Cream And Other Natural Wellness Products At The 2015 Southern California Cannabis Cup
PR Newswire - Wed Jan 28, 6:45AM CST
Tauriga Sciences, Inc. (OTCQB: TAUG) or ("Tauriga" or "the Company"
, a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology, today announced that the Company has entered its branded TopiCanna product into the Southern California Cannabis Cup to be held in San Bernardino, California on February 7-8, 2015 (http://www.cannabiscup.com/southern-california). TopiCanna will compete for an award in the Southern California Cannabis Cup, in the new Medically Infused NonEdible category. This category is reserved for products like lotions, balms, patches and suppositories. Any cannabis infused product that is not eaten or smoked can be entered in this category. Tauriga Sciences Inc. Appoints Hingge Hsu, M.D., M.B.A. to its Board of Directors
PR Newswire - Tue Jan 20, 7:00AM CST
Tauriga Sciences, Inc. (OTCQB: TAUG) or ("Tauriga" or "the Company"
, a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology, announced the appointment of Hingge Hsu, M.D., M.B.A. to its Board of Directors. Dr. Hingge Hsu was recently a Partner at Fidelity Biosciences and was on the core healthcare investment team for Fidelity Growth Partners Asia. He was previously a Managing Director at Lehman Brothers in their Private Equity Group, responsible for their principal investment activities in the private and public sectors of the healthcare industry. Dr. Hsu has structured and led numerous transactions in the life science sector, and he has been instrumental in building and growing his portfolio companies. In addition, Dr. Hsu has held operating positions at Chiron Corporation and Gensia, Inc. in the areas of business development and strategic planning. Dr. Hsu strengthens the Tauriga Board of Directors with his venture capital and investment banking experience, technical and industry knowledge, and an extensive network in both the U.S. and Asia. Moreover, he has personally invested in Tauriga Sciences based on his confidence in their strategic plan. Tauriga Sciences Inc. Announces the Launch of Its taurigastore.com eCommerce Website
PR Newswire - Thu Jan 08, 9:15AM CST
Tauriga Sciences, Inc. (OTCQB: TAUG) ("Tauriga" or the "Company"
, a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology, today launched its http://www.taurigastore.com eCommerce website. This launch allows consumers to shop online with the Company for its non-cannabis containing line of natural wellness dietary supplements. These natural supplements include IndiCalm, natural calming formula without inducing cognitive impairment; ClearNaze, a natural decongestant without stimulant or drowsiness effects; Satietiva, an amino acid-based appetite suppressant (preorder until February 2); and MendCan, a highly pure, potent and palatable Omega 3 supplement. Tauriga Sciences Confirms that Canadian Trading Halt (Cease Trade) has been Lifted by Autorite des Marches Financiers (Quebec Based regulatory Authority)
PR Newswire - Thu Jan 08, 9:00AM CST
Tauriga Sciences , Inc ("Tauriga"
(OTCQB: TAUG) announces that the Autorite des Marches Financiers ("AMF" or "Authority" , the market regulatory authority in the province of Quebec, Canada has lifted its cease trade order relating to Tauriga's securities effective June 23, 2014. Tauriga's common shares were placed on a "cease trade" or "trading halt" in Canada by the Authority for failure to file its financial statements and management's discussion and analysis for the interim fiscal periods ended June 30, 2013, September 30, 2013 and December 31, 2013 and its annual financial statements, management's discussion and analysis and annual information form for the fiscal year ended March 31, 2013 in Canada (collectively, the "Financial Documents" . Although the Financial Documents were filed by Tauriga with the Securities and Exchange Commission as required, the Financial Documents were not filed on SEDAR. The Financial Documents were filed by Tauriga on SEDAR on July 18, 2014 and are available at www.sedar.com. Tauriga Sciences Inc. Receives Additional $150,000 USD Private Placement Tranche from Tokyo Based Dragoon Capital, Inc.
PR Newswire - Wed Dec 24, 6:30AM CST
Tauriga Sciences, Inc. (OTCQB: TAUG) ("Tauriga" or "the Company"
, a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology, today announced that Tokyo, Japan based Dragoon Capital, Inc. ("Dragoon" has invested an additional $150,000 USD of private placement capital into Tauriga. This additional $150,000 USD tranche was invested at a price of $0.0125 per share (Restricted) and there were no warrants offered in conjunction with this financing. To this date, Dragoon has now invested a total of $500,000 USD of private placement capital into Tauriga. The Company plans to use this additional capital to increase production of its TopiCanna brand of topical medicinal cannabis cream and establish a marketing campaign. The Company continues to work diligently toward the completion of the definitive distribution agreement with Japanese distributor iFLOW, Inc. ("iFLOW" . In anticipation of such agreement, the Company has been developing a TopiCanna product specific for the Japanese marketplace that incorporates CBD (Cannabidiol) from the stem of the plant (to comply with the laws and regulations of Japan). Tauriga Sciences Inc. CBD (Cannabidiol) Infused TopiCanna Products Have Been Officially Launched
ACCESSWIRE - Tue Dec 16, 11:01AM CST
Los Angeles, CA / ACCESSWIRE / December 16, 2014 / Tauriga Sciences, Inc. (OTCQB: TAUG) ("Tauriga" or the "Company"
, a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology, today launched its first proprietary topical medicinal cannabis cream branded as TopiCanna. TopiCanna contains cannabidiol (CBD) oil from non-GMO industrial hemp that is grown without pesticides, herbicides, or chemical fertilizers. The oil has been lab tested for quality and is natural, safe and legal in the United States and in Japan, where Tauriga has a recently announced MOU with Tokyo-based iFLOW Ltd. There are no psychoactive effects associated with the CBD oil. Tauriga previously announced on November 25, 2014 that the Company planned to launch its TopiCanna product line within the next 60 days. TopiCanna's launch occurred well within the projected timeline. Initially the TopiCanna Products be sold directly by Tauriga Sciences, Inc. (interested parties may email inquiries to info@taurigasciences.com). The Company plans to expand TopiCanna's sales and marketing efforts to include online sales and distribution agreements, both domestically and internationally. 
